Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma
NCT07439172Phase 2Recruiting
- Sponsor
- Cooper University Health Care
- Start
- Jul 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in glioma, sponsored by Cooper University Health Care. Started Jul 2026; status: recruiting.
02
Drugs
temozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT07439172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439172.